LOX and ACSL5 as potential relapse markers for pancreatic cancer patients
In: Cancer biologytherapy, Jg. 20 (2019-02-05), Heft 6
Online
unknown
Zugriff:
Pancreatic cancer is one of the most malignant diseases and has a poor prognosis. The screening and validation of biomarkers with predictive value for prognosis and treatment efficacy are important. To identify potential prognostic markers of pancreatic cancer patients, we conducted a study that included 99 pancreatic cancer patients. Three patients with PFS>18 months were enrolled in the treat group, and three patients with PFS
Titel: |
LOX and ACSL5 as potential relapse markers for pancreatic cancer patients
|
---|---|
Autor/in / Beteiligte Person: | Li, Ting ; Wang, Xiuchao ; Li, Hui ; Wu, Si ; Li, Jian ; Ma, Weidong |
Link: | |
Zeitschrift: | Cancer biologytherapy, Jg. 20 (2019-02-05), Heft 6 |
Veröffentlichung: | 2019 |
Medientyp: | unknown |
ISSN: | 1555-8576 (print) |
Schlagwort: |
|
Sonstiges: |
|